Cargando…

Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients

BACKGROUND: Tacrolimus is a key drug in kidney transplantation with a narrow therapeutic index. However, whether tacrolimus exposure variability affects clinical outcomes and adverse reactions remains unknown. OBJECTIVE: Our study investigated the factors that influence tacrolimus exposure in kidney...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Fang, Li, Qiang, Wang, Jinglin, Hu, Min, Zeng, Fang, Wang, Zhendi, Zhang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610755/ https://www.ncbi.nlm.nih.gov/pubmed/34824543 http://dx.doi.org/10.2147/PGPM.S337947

Ejemplares similares

Retrospective Analysis of the Risk Factors of Perioperative Bacterial Infection and Correlation with Clinical Prognosis in Kidney Transplant Recipients
por: Cheng, Fang, et al.
Publicado: (2022)

Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation
por: Cheng, Fang, et al.
Publicado: (2022)

Tacrolimus Concentration Is Effectively Predicted Using Combined Clinical and Genetic Factors in the Perioperative Period of Kidney Transplantation and Associated with Acute Rejection
por: Cheng, Fang, et al.
Publicado: (2022)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

The Relationship between Initial Tacrolimus Metabolism Rate and Recipients Body Composition in Kidney Transplantation
por: Kolonko, Aureliusz, et al.
Publicado: (2021)

Systematic conversion to generic tacrolimus in stable kidney transplant recipients
por: Rosenborg, Staffan, et al.
Publicado: (2014)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
por: Han, Seung Seok, et al.
Publicado: (2012)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
por: Mansell, Holly, et al.
Publicado: (2022)

Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients
por: Francke, M. I., et al.
Publicado: (2022)

Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients
por: Lai, Elaine F., et al.
Publicado: (2022)

The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study
por: Zhao, Yi-Chang, et al.
Publicado: (2022)

A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients
por: Alloway, R R, et al.
Publicado: (2012)

Post-transplant Diabetes Mellitus in Kidney Transplant Recipients in Sudan: A Comparison Between Tacrolimus and Cyclosporine-Based Immunosuppression
por: Yousif, Elamein, et al.
Publicado: (2022)

The Association between CDKAL1 Gene rs10946398 Polymorphism and Post-Transplant Diabetes in Kidney Allograft Recipients Treated with Tacrolimus
por: Dziedziejko, Violetta, et al.
Publicado: (2023)

Coadministration of Liraglutide With Tacrolimus in Kidney Transplant Recipients: A Case Series
por: Pinelli, Nicole R., et al.
Publicado: (2013)

The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant Recipients
por: Madsen, Mads Juul, et al.
Publicado: (2017)

Genotype-guided tacrolimus dosing in African American kidney transplant recipients
por: Sanghavi, K., et al.
Publicado: (2015)

Blood Profiles of Gut Bacterial Tacrolimus Metabolite in Kidney Transplant Recipients
por: Guo, Yukuang, et al.
Publicado: (2020)

Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients
por: Suzuki, Yoshiharu, et al.
Publicado: (2021)

Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients
por: Tornatore, Kathleen M., et al.
Publicado: (2022)

Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients
por: Wings, Emily, et al.
Publicado: (2022)

Lower versus higher starting tacrolimus dosing in kidney transplant recipients
por: Chua, Justin C. M., et al.
Publicado: (2022)

Severe anorexia and weight loss induced by tacrolimus in kidney transplant recipients
por: Hwang, Hong Pil, et al.
Publicado: (2021)

Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis
por: Chen, Lizhi, et al.
Publicado: (2021)

Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function
por: Han, Seung Seok, et al.
Publicado: (2016)

Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients
por: Francke, Marith I., et al.
Publicado: (2020)

SARS-CoV-2 and Tacrolimus Blood Concentration in Kidney Transplant Recipients
por: McMinn, Jason, et al.
Publicado: (2021)

Fast Tacrolimus Metabolism Does Not Promote Post-Transplant Diabetes Mellitus after Kidney Transplantation
por: Jehn, Ulrich, et al.
Publicado: (2022)

Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
por: Dashti-Khavidaki, S., et al.
Publicado: (2016)

Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended‐release tacrolimus preparation
por: El‐Nahhas, Toqa, et al.
Publicado: (2021)

Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing
por: Dorr, Casey R., et al.
Publicado: (2018)

Impact of genetic polymorphisms at the promoter area of IL-10 gene on tacrolimus level in Jordanian renal transplantation recipients
por: Khaleel, Bara'ah, et al.
Publicado: (2022)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
por: Chen, Lucy, et al.
Publicado: (2018)

Clinical Pharmacokinetics of Tacrolimus in Iranian Liver Transplant Recipients
por: Nasiri-Toosi, Zahra, et al.
Publicado: (2014)

Gout Due to Tacrolimus in a Liver Transplant Recipient
por: Afridi, Summia Matin, et al.
Publicado: (2019)

Effects of Wuzhi Capsules on Blood Concentration of Tacrolimus in Renal Transplant Recipients
por: Yan, Lin, et al.
Publicado: (2019)

The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Cheng, Fang, et al.
Publicado: (2021)

Tacrolimus Toxicity due to Biliary Obstruction in a Combined Kidney and Liver Transplant Recipient
por: Chan, Samuel, et al.
Publicado: (2017)

Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
por: Krzyżowska, Kinga, et al.
Publicado: (2018)

Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients
por: Kannegieter, Nynke M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7hk42a06of504d02cutkic6kjd